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Abstract: Two methods for the measurement of receptor- 
activated phosphoinositide turnover were evaluated for 
their degree of correspondence in slices of rat brain; they 
involved the Li+-dependent accumulations of either [3H]- 
inositol-labeled inositol phosphates or [3H]cytidine-labeled 
CDP-diacylglycerol. In contrast to the expectation that the 
ratio of these two responses would remain approximately 
constant, varying degrees of correspondence were obtained. 
The two extremes are exemplified by carbachol, which elic- 
ited large increases in both inositol phosphate and CDP-di- 
acylglycerol labeling, and endothelin, which gave a robust 
inositol phosphate response with little or no accumulation 
of 3H-CDP-diacylglycero1. No instance of the presence of 
the latter response in the absence of 3H-inositol phosphate 
accumulation was observed. Measurement of 3H-CDP-diac- 
ylglycerol accumulation thus may add additional insight 
into the regulation of phosphoinositide turnover and the 
complex actions of Li’. Key Words: Phosphoinositide 
turnover-Inositol phosphate-CDP-diacylglycerol-Rat 
brain. Heacock A. M. et al. Measurement of receptor-acti- 
vated phosphoinositide turnover in rat brain: Nonequiva- 
lence of inositol phosphate and CDP-diacylglycerol forma- 
tion. J.  Neurochem. 60, 1087-1092 (1993). 
The phosphoinositide signal transduction pathway 
in the CNS responds to the activation of any of a num- 
ber of receptors that are distributed differentially 
throughout the brain (Fisher et al., 1992). Sustained 
formation of the second messengers inositol 1,4,5- 
trisphosphate (IP,) and diacylglycerol (DAG) in re- 
sponse to receptor activation requires the continued 
resynthesis of phosphatidylinositol 4,5-bisphosphate 
[P1(4,5)P2] via the sequential phosphorylation of 
phosphatidylinositol (PI). DAG is metabolized via 
phosphatidic acid to the liponucleotide CDP-diacyl- 
glycerol (CDP-DAG), which, in the presence of inosi- 
tol, is converted to PI in a reaction catalyzed by PI 
synthase (Agranoff et al., 1958; Paulus and Kennedy, 
1960). The latter enzyme is reported to have a rela- 
tively low affinity for inositol (Benjamins and Agra- 
noff, 1969; Ghalayini and Eichberg, 1985), and thus, 
under conditions where inositol concentrations are 
reduced, PI synthesis may be compromised. These 
considerations, together with the observation of un- 
competitive inhibition by Li’ of inositol monophos- 
phatase (Allison and Stewart, 1971), form the basis 
for an inositol depletion hypothesis to account for the 
psychotherapeutic action of Lif (Berridge et al., 1982, 
1989). Evidence in support ofthis model of Li+ action 
has been obtained recently in experiments in which 
labeled CDP-DAG was found to accumulate in carba- 
chol-stimulated rat cerebral cortex slices in the pres- 
ence of Li+ (Godfrey, 1989; Kennedy et al., 1990). Li’ 
is thought to “trap” the labeled CDP-DAG indirectly 
by inducing a substantial decrease in intracellular ino- 
sitol (a result of its block of inositol monophospha- 
tase), thus preventing further metabolism of CDP- 
DAG to PI. Whereas Godfrey (1989) also showed a 
Li+-dependent accumulation of labeled CDP-DAG in 
the presence of norepinephrine and serotonin, other 
agonists or brain regions were not investigated. For a 
given receptor, the extent of stimulation of radiola- 
beling of inositol phosphates (IP) would be expected 
to be predictive of the magnitude of radiolabeling of 
CDP-DAG. It seemed possible, in part because of the 
heterogeneity of the brain, that the relative magni- 
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tudes of the CDP-DAG and IP responses might differ 
as a function of both receptor type and brain region. 
Such information might reveal a particular focus for 
the actions of Li+. Therefore, in the  present study, the  
observations of  Godfrey ( 1  989) a n d  Kennedy et al. 
( 1990) were extended by examining the ability of ago- 
nists for six different phosphoinositide-linked recep- 
tors in different brain regions to elicit accumulation 
of CDP-DAG in parallel with that of IP. In cerebral 
cortex and  hippocampus, activation of muscarinic re- 
ceptors gave a good correspondence between these 
two measures of stimulated phosphoinositide turn- 
over, whereas varying degrees of correspondence were 
obtained for other receptors. 
MATERIALS AND METHODS 
Materials 
Carbanioylcholine (carbachol), arterenol (norepineph- 
rine), histamine, cytidine diphosphate diglyceride (dipalmi- 
toyl), cytidine, and [5-'H]cytidine ( I  5 Ci/mmol) were pur- 
chased from Sigma Chemical Co. (St. Louis, MO, U.S.A.). 
mrr~-[2-3H]Inositol ( 15 Ci/mmol) was obtained from Amer- 
sham Corp. (Arlington Heights, IL, U.S.A.). Serotonin was 
purchased from Research Biochemicals, Inc. (Natick, MA, 
U.S.A.). Quisqualic acid was from Cambridge Research Bio- 
chemicals (Wilmington, DE, U.S.A.), and endothelin-1 was 
a product of Peptides International (Louisville, KY, 
U.S.A.). Dowex 1 X 8 (100-200 mesh, formate form) was 
obtained from Bio-Rad (Rockville Centre, NY, U.S.A.). 
Measurement of labeled IP and CDP-DAG in brain 
slices 
Sprague-Dawley rats ( 13- 18 days old) were killed by de- 
capitation, and slices of cerebral cortex, hippocampus, or 
cerebellum (350 X 350 pm) were prepared on a McIlwain 
tissue chopper. Tissue was then washed several times at 
37°C in oxygenated buffer A (142 mh4 NaCI, 5.6 mMKCI, 
2.2 mM CaCl,, 3.6 m M  NaHCO,, 1 mMMgCI,, 5.6 mM 
glucose, and 30 mM HEPES, pH 7.4) and incubated, with 
shaking, in the same buffer for 60 min with one change of 
buffer aftcr 30 min. Tissue slices were then allowed to settle, 
and 50 pl of gravity-packed slices (0.8-1.2 mg of protein) 
were transferred to flat-bottomed plastic minivials and 
incubated with 350 pl of buffer A containing either 5 pCi of 
myo-[2-3H]inositol or 3 pCi of [S3H]cytidine at 37°C for 60 
min. LiCl was then added to a final concentration of 5 m M  
(50 pi of 50 mM). In preliminary experiments, 5 mM LiCl 
was found to be optimal for both IP and CDP-DAG accu- 
mulations. After 10 min, 100 pI of buffer or agonist were 
added to duplicate tubes. Reactions were stopped after 30 
min by addition of 1.7 ml of chloroform/methanol (1  :2, 
vol/vol). Preliminary experiments indicated that formation 
of 1P or CDP-DAG for all agonists in all three tissues re- 
mained approximately linear for at least 30 min. For tissue 
labeled with [3H]inositol, total radioactivity in IP was deter- 
mined following ion-exchange chromatography as de- 
scribed previously (Fisher et al., 1984; Heacock et al., 1987). 
Aliquots of the lower phases were also removed for determi- 
nation ofradioactivity in inositol phospholipids. Lipid label- 
ing, in general, was unchanged by incubation with agonist. 
Where small increases did occur (<20%), there was no ap- 
parent correlation with the extent of IP labeling, and thus 
the data presented are based on total disintegrations of IP 
per minute per tube, without correction for lipid labeling. 
For tissue labeled with ['Hlcytidine, phases were separated 
by addition of 1 ml of chloroform and 0.5 ml of I .2 MHCI, 
and the lower phase was then washed twice with 2.0 ml of 
acidified Folch theoretical upper phase containing 5 mM 
cytidine. A 1 -ml aliquot of the lower layer was then trans- 
ferred to a scintillation vial and dried prior to measurement 
of radioactivity. Analysis of zero time control samples indi- 
cated that less than 2% of the basal chloroform-extractable 
radioactivity could have been due to contaminants in the 
radiolabeled precursor. Duplicate determinations of either 
'H-IP or 'H-CDP-DAG differed by no more than 10%. Data 
are expressed as percent stimulation above basal [(experi- 
mental - basal)/basal X 1001. To verify the identity of ra- 
diolabeled CDP-DAG formed in the tissue slice incuba- 
tions, samples of [3H]cytidine-labeled chloroform-soluble 
material were subjected to thin layer chromatography on 
oxalate-impregnated plates with the solvent chloroform/ 
acetone/methanol/acetic acid/water (40: 15: 1 3: 12:8, by vol- 
ume; Downes and Stone, 1986). Thin layer chromato- 
graphic analysis of both the basal and carbachol-stimulated 
[3H]~ytidine-labeled lipid extracts from cerebellum and cor- 
tex indicated that 8-1 5% of the radioactivity remained at 
the origin, 72-85% comigrated with authentic CDP-DAG 
(R,  = 0.41), and 3-6% migrated more rapidly (R, = 0.66) 
and also increased with carbachol treatment. The identity of 
the latter component is unknown. 
Measurement of tissue inositol concentration 
A modification ofthe method of Mount and Laker ( I  98 I )  
was utilized. Intact dissected brain tissue or incubated tissue 
slices (1-2 mg of protein) were homogenized in deionized 
water, and then I .5 ml of chloroform/methanol (1:2, vol/ 
vol) and 1 ml each of chloroform and deionized water were 
added. Xylitol (50 pg/sample) was included as an internal 
polyol standard. Following separation of phases, the 
aqueous upper phase was dried in vacuo and stored over 
phosphorus pentoxide for 30-60 min prior to acetylation. 
Dried samples were then treated with 0.5 ml of distilled 
pyridine at 70°C for 30 min, followed by the addition of0.5 
ml of acetic anhydride and incubation for 10 min at 70°C. 
Samples were then vacuum-dried and stored over phospho- 
rus pentoxide. Dried acetylated samples were dissolved in 
10-20 pl of chloroform, and 2 pl were applied to an SP 2330 
capillary column of a Hewlett-Packard gas chromatograph. 
The peaks were then integrated, and the inositol values were 
corrected for recovery of the xylitol standard. Values are 
expressed as nanomoles per milligram of protein. 
Protein was measured by the method of Geiger and Bess- 
man (1972). 
PI synthase measurement 
Assay of PI synthase was carried out by a modification of 
the method of Fischl and Carman (1983). Tissue was ho- 
mogenized in  9 volumes of 50 MTris -HC1,  pH 8.0,0.32 
M sucrose, 1 mM EGTA, 0.5 m M  dithiothreitol, and then 
centrifuged at 100,000 g for 60 min. The membrane pellet 
was resuspended in the same buffer, and aliquots were incu- 
bated at 37°C for 30 min in a volume of 200 pl with the 
following reagents (final concentration): 50 m M  Tris-HCI 
buffer, pH 8.0, 1 mA4 EGTA, 0.1% Triton X-100, 3 mM 
MnCI,, 20 mM MgCl,, 0.2 mh4 CDP-DAG [dipalmitoyl; 
chloroform/methanol (1: 1 )  solution, dried under N, and 
sonicated in buffer], and 0.1-10 p M  [3H]inositol (10 pCi/ 
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Fmol). Reactions were stopped by addition of 1.7 ml of 
chloroform/methanol ( 1 :2) and acid-extracted, and then 
aliquots of the lower layer were dried in scintillation vials 
for determination of radioactivity. 
RESULTS 
Comparison of IP and CDP-DAG responses 
The relative abilities of agonists for six phosphoino- 
sitide-linked receptors to elicit increases in accumula- 
tion of both IP and CDP-DAG were determined in 
three regions of 1 3- 1 8-day rat brain (Fig. 1). This age 
was chosen to ensure optimal stimulation of phos- 
phoinositide turnover by many of these agonists (Nic- 
oletti et al., 1986; Heacock et al., 1987). The largest 
stimulations of 3H-IP formation were elicited by acti- 
vation of endothelin (ET- l), glutamate (quisqualate), 
or muscarinic (carbachol) receptors, whereas activa- 
tion of adrenergic (norepinephrine) and histaminer- 
gic (histamine) receptors was less effective (see Fig. 1). 
Measurement of 3H-CDP-DAG accumulation re- 
vealed a very different pattern. The best correspon- 
dence between these two measures of stimulated 
phosphoinositide turnover was exhibited for the re- 
sponse to activation of the muscarinic receptor in cor- 
tex and hippocampus by carbachol. In contrast, for 
the cerebellum, the IP and CDP-DAG responses to 
carbachol were less well correlated. The cerebellum 
also differed from the other two brain regions in that it 
exhibited fourfold higher basal levels of 3H-CDP- 
DAG labeling (legend to Fig. 1). The dose-response 
curve for stimulation of IP formation by carbachol in 
the cerebral cortex closely resembled that for accumu- 
lation of CDP-DAG (data not shown), with EC,, val- 
ues of 100 pM and 85 pM, respectively. Inclusion of 
10 yM atropine blocked both responses to 1 mA4 car- 
bachol by 98-99%, while having no effect on basal 
3H-IP or 3H-CDP-DAG formation. The other ago- 
nists examined exhibited lesser degrees of correspon- 
dence between the two assays, with the extreme exem- 
plified by endothelin-1, which gave a large IP re- 
sponse in all three brain regions, but elicited increases 
in CDP-DAG of only 8- 12% above basal. For the glu- 
tamate analogue quisqualic acid, a possible indirect 
effect on 3H-lP accumulation, mediated by the iono- 
tropic rather than the metabotropic glutamate recep- 
tor, was explored. In agreement with most previous 
reports (Recasens et al., 1988; Godfrey and Taghavi, 
1990; Schoepp and Hillman, 1990; but see also Baird 
et al., 199 l), the ionotropicglutamate receptor antago- 
nists, 6-nitro-7-cyanoquinoxaline-2,3-dione and 6,7- 
dinitroquinoxaline-2,3-dione (Honor6 et al., 1988), 
were found to have no effect on the IP response elic- 
ited by quisqualic acid in any of the three brain re- 
gions examined (data not shown). 
In a more limited series of experiments, the re- 
sponses to serotonin in cerebral cortex were also exam- 
ined. Serotonin, at 100 pM, increased labeling of IP 
by 116 f 45% (n = 4), whereas 3H-CDP-DAG in- 
creased, in a Li+-dependent manner, by 84 ? 17% (n 
= 4). Threefold larger increases in the latter (but not 
the former) were obtained with 1 mM serotonin; how- 
ever, this was determined to be a nonreceptor-me- 
diated, Li'-independent effect, which could be mim- 
icked by other structurally similar cationic amphiphi- 
lic compounds (Hauser and Eichberg, 1975; Eichberg 
et al., 1979). 
The possibility that the observed differential CDP- 
DAG responses may reflect differences in [3H]- 
cytidine uptake or in intracellular cytidine or cytidine 
nucleotide content was considered. If the robust 
CDP-DAG response to carbachol was an artifact due 
to increased specific activity of cytidine pools in the 
environment of the muscarinic receptors, then addi- 
tion of increasing amounts of unlabeled cytidine 
might be expected to reduce the response. Such was 
not the case, because addition of 1, 10, or 30 pM cyti- 
dine to cerebral cortex slices, although reducing the 
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FIG. 1. Comparison of IP and CDP-DAG responses. Slices of cortex, hippocampus, or cerebellum from 13-1 8-day rats were prelabeled 
with [3H]inositol or [3H]cytidine, as described in Materials and Methods, and then incubated with the indicated concentrations of agonists 
for 30 min in the presence of 5 mM LiCI. Radioactivity in IP or CDP-DAG was then determined. Data are expressed as percent stimulation 
above basal (means & SEM) for the number of experiments indicated below. Basal values for a typical experiment for cortex (ctx), 
hippocampus (hip), and cerebellum (cb) were 3,735, 6,566, and 5,682 dpm for IP and 4,259, 4,195, and 16,186 dprn for CDP-DAG, 
respectively. Agonists were used at or above their maximally effective concentrations for stimulation of phosphoinositide turnover. The 
concentrations and number of experiments for each agonist are as follows: carbachol (CCh; 1 mM, n = 6), quisqualate (QUIS; 100 pM, n 
= 5), norepinephrine (NE; 100 pM, n = 3), histamine (HIST; 1 rnM, n = 4), and endothelin-1 (ET-1; 0.5 pM, n = 4). 
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radioactivity associated with CDP-DAG by 28, 74, 
and 90%, respectively, resulted in carbachol-stimu- 
lated CDP-DAG labeling of 1,410, 1,330, and 
1,520%. Neither did addition of carbachol have any 
effect on labeling of cytidine nucleotides as deter- 
mined by measurement of water-soluble [3H]- 
cytidine-labeled material bound to and then eluted 
from Dowex-formate columns (data not shown). 
Effect of Li" and reversibility by inositol 
The dependence on the presence of LiCl for stimu- 
lated formation of both IP and CDP-DAG was exam- 
ined. In cerebral cortex, basal 1P and CDP-DAG label- 
ing were both reduced by approximately 20% in the 
absence of Li+. Omission of Li+ resulted in a 77-85% 
reduction in the stimulated IP formation elicited by 
all five agonists, in all three brain regions, when com- 
pared with the maximum values obtained in the pres- 
ence of 5 m M  Li+. Stimulation of 3H-CDP-DAG ac- 
cumulation by carbachol, quisqualate, and norepi- 
nephrine showed an even greater dependence upon 
Li+, with a 97-100% reduction in its absence. The 
effect of Li+ omission on the small histamine and en- 
dothelin CDP-DAG responses was not examined. 
The ability of inositol to reverse the agonist-in- 
duced or basal accumulation of CDP-DAG in cere- 
bral cortex was then explored. A concentration-de- 
pendent reduction in 3H-CDP-DAG accumulation 
was observed upon addition of inositol for all three 
agonists examined (Fig. 2), with EC,, values for inosi- 
to1 of 0.6- 1.5 mM, values similar to those previously 
reported for reversal of the carbachol response (God- 
frey, 1989; Kennedy et al., 1990). Reversal of the ba- 
sal ,H-CDP-DAG accumulation (Fig. 2, inset) re- 
quired nearly 10-fold less inositol (EC,, = 0.17 f 0.1 
0 
log [~no~i to l ]  M 
U CCh -QUIS 
--D- NE 
---b basal 
0 1  
-5 -4 -3 -2 -1 
log [inositol] M 
FIG. 2. lnositol reversal of CDP-DAG accumulation in rat cerebral 
cortex slices. Experiments were carried out as in Fig. 1, using the 
same concentrations of agonists, except that the indicated con- 
centrations of inositol were added together with the Lif after the 
60-min prelabeling period. The inositol EC,, values were as fol- 
lows: carbachol (CCh; 1.5 * 0.3 rnM, n = 6); quisqualate (QUIS; 
0.64 & 0.07 mM, n = 4); norepinephrine (NE; 1.1 rt_ 0.2 mM, n 
= 4). Inset: lnositol reversal of basal 3H-CDP-DAG accumulation. 
TABLE I .  Inositol content of' rat bruin regions 
Intact tissue Incubated slices 
Cortex 22.7 -t 0.3 8.2 i 0.2 
Hippocampus 30.3 i 0.9 11.5 i 0.8 
Cerebellum 38.3 * 0.9 17.1) i 1.0 
Tissue dissected from 15-day rat brain was homogenized immedi- 
ately or sliced and incubated for 2.5 h at 37°C in the absence ofLi', 
as described in Materials and Methods. lncubated slices were then 
pelleted and homogenized, and the inositol content and protein 
concentration determined. Data, given in nmol/mg of protein, are 
expressed as means t SEM (n = 3) for one of two experiments, 
which gave similar results. 
mM, n = 10). Of relevance to interpreting these re- 
quirements for inositol is the inositol concentration of 
the incubated brain slices and the kinetic properties of 
PI synthase. The latter is reported to have a K, for 
inositol of 1.5-4.6 mA4 (Benjamins and Agranoff, 
1969; Ghalayini and Eichberg, 1985). Determination 
of the inositol concentration dependence of PI syn- 
thase in a crude particulate fraction from rat cortex 
indicated a K, of 0.9 1 k 0.04 mA4 (mean t SEM, n 
= 3 ) ,  similar to the values obtained for the EC5, for 
inositol reversal of agonist-stimulated CDP-DAC ac- 
cumulation (Fig. 2). Preparation of slices from adult 
rat cortex is reported to result in an 80% loss of tissue 
inositol content (Sherman et al., 1986). Therefore, 
measurements of inositol in incubated brain slices 
were carried out and the values compared to those for 
intact tissue (Table 1). The inositol concentration in 
15-day rat brain regions (2-4 M) was less than that 
reported for whole adult rat brain (5-6 mM, Sherman 
et at., 1977, 1986). This appears to be a developmen- 
tal difference rather than a loss of inositol due to the 
dissection procedure, because the same procedure ap- 
plied to adult rat brain gave values in agreement with 
those previously found for whole brain (Stubbs and 
Agranoff, unpublished observations). Following incu- 
bation of slices prepared from 15-day brain regions, 
inositol content was reduced by 56-64010. The concen- 
tration of inositol in incubated cerebral cortex slices 
may be approximated at 1 m M  or less, a value which 
is in agreement with both the K, for inositol of PI 
synthase and the EC,, for inositol reversal of LP-sen- 
sitive CDP-DAG formation. 
DISCUSSION 
Activation of phosphoinositide-linked receptors re- 
sults in the hydrolysis of PI(4,5)P2 to yield equivalent 
amounts of IP, and DAG. The widely used [3H]- 
inositol-labeling technique (Berridge et al., 1982) per- 
mits rapid assessment of phosphoinositide turnover 
by quantitatively trapping inositol monophosphates, 
degradation products of IP,, in the presence of Li+. A 
method for indirectly assessing DAG formation was 
provided by the demonstration by Downes and Stone 
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( 1986), in parotid gland, of a carbachol-stimulated, 
Li+-dependent accumulation of 32P, or [3H]cytidine- 
labeled CDP-DAG. These observations, as well as the 
studies of Godfrey ( 1989) and Kennedy et al. (1 990), 
provide not only an alternative technique for measure- 
ment of phosphoinositide turnover, but also lend sup- 
port to the inositol depletion hypothesis as a mecha- 
nism for the psychotherapeutic actions of Li+. In the 
present study, the extent of correlation between these 
two measures of phosphoinositide turnover for differ- 
ent receptors and brain regions was explored. The ra- 
tios of the IP to CDP-DAG responses would be ex- 
pected to be rather uniform, although not necessarily 
unity, bccause neither response would accurately re- 
flect chemical mass due to lack of isotopic equilib- 
rium in the brain slice preparation. In contrast to this 
expectation, the extent of correlation between these 
two measures of phosphoinositide turnover was 
found to be quite variable in all three brain regions 
examined. For example, if the ratio of the CDP-DAG 
to IP responses for the muscarinic receptor in cerebral 
cortex is normalized to 1 .O, then the relative ratios for 
the following receptors are as follows: serotonin, 0.7; 
norepinephrine, 0.4; glutamate, 0.16; histamine, 
0.02; and endothelin, 0.01. These results for carba- 
chol, norepinephrine, and serotonin are in general 
agreement with those reported by Godfrey (1989) for 
this brain region. From the data presented here, it 
appears that the 3H-CDP-DAG assay method may 
not be so widely applicable as the 3H-IP method for 
assessment of stimulation of inositol lipid turnover. 
In addition, the present results also suggest limitations 
to the utility of the CDP-DAG-based autoradio- 
graphic method for localization of receptor-mediated 
phosphoinositide turnover in brain (Hwang et al., 
1990). Although further interpretation of these results 
must remain tentative due to the likely presence of 
multiple pools of these inositol lipid metabolites and 
to the absence of mass data for CDP-DAG or IP, the 
inability of endothelin and histamine to elicit a 3H- 
CDP-DAG response suggests that the DAG formed 
from PI(4,5)P2 hydrolysis is not being efficiently 
trapped as CDP-DAG. Inefficient trapping of DAG as 
CDP-DAG may occur for any of a number of reasons, 
including an alternative metabolic fate for DAG or 
phosphatidic acid, a high inositol content in the vicin- 
ity of these receptors, or the existence of a PI synthase 
with a relatively low K,,, for inositol (Imai and Gersh- 
cngorn, 1987). Thus far, no CDP-DAG response has 
been obtained i n  the absence of an IP response. That 
the converse is true (i.e., for endothelin and hista- 
mine) suggests that the use of these two assays in com- 
bination may provide more insight into the regulation 
of phosphoinositide turnover and the effects of Li+ on 
this signal transduction pathway than either alone. 
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